Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,193.00    -7.00 (-0.58%)
Bid:
1,197.00
Ask:
1,201.00
Spread: 4.00 (0.334%)
Market Cap: £829.64m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
19th Feb 20104:20 pmRNSInterim Results
19th Feb 20104:20 pmRNSProposed placing and Acquisition
10th Dec 20097:00 amRNSAnnual General Meeting Statement
7th Dec 200910:07 amRNSHolding(s) in Company
7th Dec 20097:00 amRNSAppointment of Nominated Advisor and Broker
1st Dec 20097:00 amRNSAcquisition
18th Nov 20095:19 pmRNSPosting of Annual Report
11th Nov 200910:58 amRNSChange of Registered Office
3rd Nov 20097:00 amRNSHolding(s) in Company
3rd Nov 20097:00 amRNSHolding(s) in Company
20th Oct 200910:35 amRNSHolding(s) in Company
20th Oct 200910:07 amRNSHolding(s) in Company
19th Oct 200910:19 amRNSHolding(s) in Company
16th Oct 200911:52 amRNSDirector/PDMR Shareholding
25th Sep 20095:08 pmRNSDirector/PDMR Shareholding
24th Sep 20094:03 pmRNSHolding(s) in Company
22nd Sep 20097:00 amRNSPreliminary Results
15th Sep 200911:26 amRNSHolding(s) in Company
3rd Sep 200912:03 pmRNSHolding(s) in Company
28th Aug 20098:18 amRNSHolding(s) in Company
27th Aug 20094:53 pmRNSHolding(s) in Company
27th Aug 200912:08 pmRNSHolding(s) in Company
27th Aug 20098:57 amRNSHolding(s) in Company
26th Aug 20094:08 pmRNSHolding(s) in Company
26th Aug 20092:47 pmRNSHolding(s) in Company
7th Aug 20096:24 pmRNSHolding(s) in Company
17th Jul 20097:00 amRNSAcquisition
14th Jul 20097:00 amRNSTrading Update
13th Jul 20097:00 amRNSLTIP Award
30th Apr 20094:10 pmRNSHolding(s) in Company
21st Apr 20097:00 amRNSAcquisition
14th Apr 200910:48 amRNSHolding(s) in Company
7th Apr 20095:22 pmRNSHolding(s) in Company
2nd Apr 20094:08 pmRNSHolding(s) in Company
25th Mar 20099:50 amRNSHolding(s) in Company
24th Mar 20098:00 amRNSDirector/PDMR Shareholding
17th Mar 20097:00 amRNSInterim Results
3rd Mar 20097:00 amRNSAcquisition
27th Feb 20098:30 amRNSNotice of Results
6th Feb 20093:25 pmRNSHolding(s) in Company
29th Jan 20094:32 pmRNSHolding(s) in Company
20th Jan 20093:47 pmRNSHolding(s) in Company
20th Jan 20097:00 amRNSAcquisition
13th Jan 20097:00 amRNSBoard Change
8th Dec 20087:00 amRNSDirector Dealings
4th Dec 20083:15 pmRNSAGM Result
4th Dec 20087:00 amRNSAnnual General Meeting Statement
2nd Dec 20087:00 amRNSAcquisition of Joel Veterinary Clinic Ltd
2nd Dec 20087:00 amRNSAcquisition of Harbour Veterinary Group
28th Nov 20082:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.